This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Serine/threonine-protein kinase VRK2.
Inhibition of signal transmission mediated by the assembly of MAPK8IP1-MAPK complexes reduces JNK phosphorylation and JUN-dependent transcription. Phosphorylates'Thr-18' of p53/TP53, histone H3, and might also phosphorylate MAPK8IP1.
Human | |
---|---|
Gene Name: | VRK2 |
Uniprot: | Q86Y07 |
Entrez: | 7444 |
Belongs to: |
---|
protein kinase superfamily |
EC 2.7.11.1; serine/threonine-protein kinase VRK2; vaccinia related kinase 2; vaccinia virus B1R-related kinase 2; Vaccinia-related kinase 2; vaccinia-related kinase-2
Mass (kDA):
58.141 kDA
Human | |
---|---|
Location: | 2p16.1 |
Sequence: | 2; NC_000002.12 (57907651..58163993) |
Isoform 1 and isoform 2 are expressed in various tumor cell lines. Expression of isoform 1 inversely correlates with ERBB2 in breast carcinomas (at protein level). Widely expressed. Highly expressed in fetal liver, skeletal muscle, pancreas, heart, peripheral blood leukocytes and testis.
[Isoform 1]: Cytoplasm. Endoplasmic reticulum membrane; Single-pass type IV membrane protein. Mitochondrion membrane; Single-pass type IV membrane protein. Nucleus envelope.; [Isoform 2]: Cytoplasm. Nucleus.
PMID: 9344656 by Nezu J., et al. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to Vaccinia virus B1R kinase.
PMID: 16704422 by Blanco S., et al. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines.